ABEO Latest Headlines

Abeona Expands Access to ZEVASKYN in Texas: UTMB Galveston Now a Qualified Treatment Center

Market Chameleon (Thu, 11-Dec 8:36 AM)

Abeona's ZEVASKYN Marks a Pivotal Milestone: First Patient Treated with FDA-Approved Gene Therapy for RDEB

Market Chameleon (Mon, 8-Dec 8:21 AM)

Abeona’s ZEVASKYN Launch Accelerates with Growing Patient Demand and Strong Cash Position

Market Chameleon (Wed, 12-Nov 10:39 AM)

CMS Assigns Permanent J-Code to ZEVASKYN—Paving the Way for Broader Access in Rare Disease Gene Therapy

Market Chameleon (Thu, 30-Oct 11:34 AM)

Abeona's ABO-503 Gene Therapy Chosen for FDA Rare Disease Pilot—A Milestone for XLRS Treatment Development

Market Chameleon (Mon, 13-Oct 8:19 AM)

Abeona Therapeutics Expands ZEVASKYN Access: Children’s Hospital Colorado Named Newest Treatment Center

Market Chameleon (Wed, 8-Oct 10:23 AM)